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APPLICATION OF DIFFERENTIAL OUTCOMES TO A COCAINE-SALINE
DISCRIMINATION PROCEDURE: ASSESSMENT OF STIMULUS
GENERALIZATION TO DOPAMINE
D3 RECEPTOR AGONISTS
Kelly J. Garner, M.A.
Western Michigan University, 1999
This study replicated the effects of differential outcomes on the acquisition of
a cocaine-saline discrimination in rats and examined whether learning via differential
outcomes (DO) influenced stimulus generalization to other drugs. Previous
investigations have suggested that the dopamine (DA) D3 receptor subtype may
modulate the reinforcing effects of cocaine. Pharmacological compounds which have
been identified as having a greater affinity for DA D3 receptors are 7-OH-DPAT and
PD 128907. The present study examined whether the DO conditions applied during
training had an impact on the generalization of these test compounds. Two groups of
male Sprague-Dawley rats were trained to discriminate 10 mg/kg cocaine from saline.
After reaching discrimination criterion, subjects were exposed to stimulus
generalization tests. Results show that the DO group met the discrimination criterion
in significantly fewer sessions than the control group. Results of stimulus
generalization tests show no significant differences between training groups. Data
suggest that differential outcomes can be applied to a cocaine-saline discrimination
without altering stimulus generalization.
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INTRODUCTION
The Drug Discrimination Assay
Drug discrimination assays are used to examine the stimulus properties of
drugs. "In discrimination training, the effects of a drug serve as discriminative
stimuli that indicate to a subject when or how it can obtain reinforcers" (Stolerman,
1993, p. 218). Typical drug discrimination assays involve the use of a two-lever
operant conditioning procedure. A drug discrimination is established by differentially
reinforcing one response (e.g., a press on one lever) after drug administration and
another response (e.g., a press on the other lever) after administration of vehicle (no
drug) or another drug (Branch, 1991). If differential performance is established, that
is, if the subject presses one lever after drug administration and the other lever after
vehicle administration, one can conclude that the interoceptive physiological and
psychological stimulus effects of the drug are serving as discriminative stimuli.
Therefore, it can be concluded that the behavior of the subject is under discriminative
stimulus control of the drug. Once a discrimination is established, novel compounds
can be administered via the assay in order to classify their effects compared to the
effects of known compounds.
The Differential Outcomes Procedure
Drug discrimination research is labor intensive, requiring one to invest a
1

great deal in time, effort, and planning (Stolerman, 1993). Most studies require 10-12
months to complete. One possible way to reduce the time needed for acquisition of
discrimination involves the use of differential outcomes. The differential outcomes
effect "refers specifically to the increase in speed of acquisition or terminal accuracy
that occurs in discrimination training when each of two or more discriminative stimuli
is correlated with a particular outcome (e.g., type of reinforcer)" (Goeters, Blakely, &
Poling, 1992, p. 389). Previous research has shown that the acquisition of a cocaine
saline discrimination is accelerated when differential outcomes (water vs. diluted
sweetened-condensed milk) are used during discrimination (cocaine vs. saline)
training (Morgan & Baker, 1997). The same research has also shown that the use of
differential outcomes does not significantly alter the cocaine dose-response curve,
although there is some variability between groups. However, it has not been
determined whether learning via differential outcomes, as opposed to non-differential
outcomes, has an effect on organisms' ability to generalize to the stimulus effects of
other drugs given during later testing phases (i.e., substitution tests). It is important to
know whether there would be such an effect, especially if investigators use
differential outcomes conditions in drug discrimination research.
Pharmacology
Because a major focus of drug discrimination research is to identify
compounds that may aid in the pharmacological treatment of drug/substance abuse, it
is important to control for factors that may affect the generalization (i.e., substitution)
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of a particular compound. It is generally well established that drugs with similar
pharmacological mechanisms exhibit generalization to one another in drug
discrimination investigations. To determine whether the differential outcomes effect
influences generalization of test compounds, a suitable test compound must be
selected.
Many investigations have focused on identifying the neuronal systems
involved in the mediation of reinforcement of drugs of abuse. Initial studies of brain
self-stimulation have shown that the areas to which rats will work to self-administer
electrical stimulation are specifically those areas that contain a greater concentration
of dopaminergic (DA) neurons (Gallistel, Gomita, Yadin, & Campbell 1985; Olds &
Fobes, 1981); those areas are the mesolimbic regions of the brain. The finding that
mediation of reinforcement is related to the concentration levels of DA neurons
present in certain areas of the brain suggests that DA is involved in the modulation of
reinforcement. Further evidence for this hypothesis is seen in the relationship
between psychomotor stimulants, such as cocaine, and the neurotransmitter
dopamine, which has been extensively examined and documented. As a DA agonist,
cocaine produces its reinforcing effects by blocking pre-synaptic reuptake of DA
(Koob & Bloom, 1988; Johanson & Fischman, 1989). By preventing the reuptake of
DA, the intensity and functional availability of pre- and post-synaptic DA is sustained
for a greater period of time (Caine & Koob, 1995). Those brain areas that are
hypothesized to mediate reinforcement of psychomotor stimulants contain a greater
number of the D2 subfamily of DA receptors (Bouthenet, Souil, Martres, Sokoloff,

Giros, & Schwartz, 1991; Landwehrmeyer, Mengod, & Palacois, 1993). Recent
investigations have suggested that psychomotor stimulants specifically target the D2
subfamily of DA receptors, which consist of the D2, D3, and D4 subtypes. In fact,
research investigating the relation between cocaine and DA has recently focused on
the DA D3 receptor subtype(Spealman, 1996; Gehlert, Gackenheimer, Seeman, &
Schaus, 1992). A greater concentration of this subtype is found in the mesolimbic
areas of the brain, areas that play a role in mediating the reinforcing properties of
psychostimulants(Levesque, Diaz, Pilon, Martres, Giros, Souil, Schott, Morgat,
Schwartz, & Sokoloff, 1992). These findings suggest that this subtype in particular
may modulate the reinforcing effects of cocaine(Acri, Carter, Alling, Douglass,
Dijkstra, Wikstrom, Katz, & Witkin, 1995; Landwehrmeyer et al., 1993). Therefore,
it could be argued that the compounds to be tested in the present study have a greater
affinity for the D2 subfamily of DA receptors, especially the D3 subtype.
Pharmacological compounds which have been identified as having a greater
affinity for DA D3 receptors are 7-OH-DPAT, in both is racemic and(+) isomer
forms, and PD 128907. It has been reported that 7-OH-DPAT exhibits a 100-fold or
greater affinity for D3 over D2 receptors(Burris, Pacheco, Piltz, Kung, Kung, &
Molinoff, 1995; Levesque et al. 1992), and PD 128907 has been reported to have at
least a 300-fold or greater D3 vs. D2 selectivity(Pugsley, Davis, Akunne, MacKenzie,
Shih, Damsma, Wikstrom, Whetzel, Georgie, Cooke, DeMattos, Corbin, Glase, Wise,
Dijkstra, & Heffner, 1995; Spealman, 1996). At this time, these compounds are two
of the most selective DA D3 agonists available for study.
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Several studies have investigated the stimulus generalization of DA D3
selective agonists in animals trained to discriminate specific psychomotor stimulants
from saline. The discriminative stimulus effects of cocaine have been shown to
generalize to the selective D3 agonists(±) 7-OH-DPAT and PD 128907 in rats(Acri
et al., 1995) and rhesus monkeys(Lamas, Negus, Nader, & Mello, 1996); that is, in
those subjects,(±) 7-OH-DPAT and PD 128907 substituted for cocaine. Baker,
Svenson, Garner, & Goodwin(1998) found that(+) 7-OH-DPAT exhibited partial
substitution (between 20% and 80% drug-appropriate responding) in rats trained to
discriminate cocaine(5 mg/kg) from saline. Spealman(1996) also found that both 7OH-DPAT and PD 128907 partially substituted for cocaine in squirrel monkeys
trained on a cocaine-saline discrimination. Other studies have noted similar results
using self-administration assays. 7-OH-DPAT maintained self-administration
responding when substituted for cocaine in rats(Caine & Koob, 1993, 1997) trained
to self-administer cocaine. Both 7-OH-DPAT and PD 128907 have been shown to
maintain self-administration when substituted for cocaine in rhesus monkeys(Nader
& Mach, 1996) trained to self-administer cocaine. Similar results have been found in
studies using other psychomotor stimulants. For example, Bevins, Klebaur, & Bardo
(1997) and Baker et al. (1998) found that 7-OH-DPAT fully substituted ford
amphetamine in rats. Therefore, if these highly selective DA D3 compounds are
tested for generalization in subjects trained to discriminate between cocaine and
saline using differential outcomes and in subjects trained without differential
outcomes, it can be concluded that any differences observed in degree of
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generalization are due to the use of differential outcomes.
Objectives
In summary, the two primary objectives of this study are (1) to replicate the
differential outcomes effect on a saline-cocaine discrimination procedure in rats; and
(2) to examine whether the differential outcomes conditions applied during training
have an impact on the generalization of the dopamine D3 receptor agonists (±) 7-OH
DPAT, (+) 7-OH-DPAT, and PD 128907 administered during substitution testing.

METHOD
Subjects
Twenty-four experimentally naive Sprague-Dawley rats (Harlan Breeding
Laboratories, Indianapolis, IN), 60-90 days of age at the beginning of the study,
served as subjects. Subjects were individually housed in wire mesh cages in a colony
room maintained on a 12-h light/dark cycle and at a relatively constant temperature
(20-22° C) and humidity (50-65%). Commercial rat feed was available ad libitum.
For control subjects, water served as the reinforcer during experimental sessions.
Subjects in the differential outcomes group alternately received a diluted (2 parts
water: 1 part milk) sweetened condensed milk solution or water as reinforcers
(Morgan and Baker, 1997). Additional access to water was given to all subjects
during 20 min post-session periods and every ?1h day for approximately 24 h. The
animals were maintained in accordance with the general principles of animal
husbandry outlined by the National Institutes of Health and the experimental protocol
was reviewed and approved by the Institutional Animal Care and Use Committee of
Western Michigan University (see Appendix A).
Drugs
Cocaine-hydrochloride was obtained from the National Institute on Drug
Abuse (Rockville, MD).(+) 7-OH-DPAT was obtained from Pharmacia & Upjohn,
7
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Inc.(Kalamazoo, MI). PD 128907 and(±) 7-OH-DPAT were purchased from
Research Biochemicals International (Natick, MA). All drugs were dissolved in
0.90% bacteriostatic sodium chloride. Cocaine and(±) 7-OH-DPAT were
administered intraperitoneally(IP.); (+) 7-OH-DPAT and PD 128907 were
administered both subcutaneously(SC) and IP. All doses of each drug were based on
the salt.
Apparatus
All experimental sessions were conducted in eight standard light and sound
attenuating operant chambers(MED Associates, Inc., St. Albans, VT. ENV-001).
Two response levers were mounted on the front panel of each operant chamber.
Liquid reinforcers(0.1ml) were delivered via a dipper mechanism mounted between
the two response levers. Each chamber contained a 28 V houselight to provide
illumination and an exhaust fan to provide masking noise and ventilation. A Zenith
320-SX microcomputer programmed with MED-PC instrumentation and software
(MED Associates Inc., St Albans, VT, version 2.0) was used to control experimental
events and data collection.
Shaping
The shaping phase consisted of one 8 h experimental session. During this
session subjects were placed in the operant chambers overnight. Only the center lever
was present during this session, and responses on this lever were reinforced under a
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fixed-ratio 1 (FR 1) schedule of reinforcement. Only water reinforcers were
delivered during the shaping phase. No injections were given during this session.
Those subjects that did not acquire the lever press response during this session
received shaping during the experimental training sessions as needed.
Training Procedures
All subjects were trained to discriminate cocaine (10 mg/kg) from saline using
a two-lever operant task under a fixed-ratio (FR) schedule of liquid reinforcement.
Cocaine and saline injections were administered in a pseudo-random order across
sessions to ensure that no subject was given more than two consecutive cocaine
conditions or two consecutive saline conditions. All injections were administered 15
min prior to the beginning of each training session. Subjects were randomly assigned
to either the differential outcomes condition or the control condition. Six of the 12
subjects in the differential outcomes condition received water as the reinforcer for
correct responses during saline sessions and sweetened condensed milk as the
reinforcer for correct responses during cocaine sessions; these conditions were
reversed for the remaining six subjects. All subjects in the control condition received
water as the reinforcer for correct responses during both saline and cocaine sessions.
For half of the subjects in each group, left lever presses were reinforced after cocaine
injections and right lever presses were reinforced after saline injections; these
conditions were reversed for the remaining subjects in each group. Response levers
were wiped with isopropyl alcohol prior to each session in order to reduce the
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influence of olfactory stimuli on lever pressing (Extance & Goudie, 1981).
Experimental sessions lasted 20 min and were conducted 5-6 days a week. To control
for olfactory stimuli that may result from using sweetened condensed milk and water
as reinforcers, small cups containing sweetened condensed milk were placed behind
the front panel of each chamber. All subjects were trained under a FR 1 schedule of
reinforcement. This response requirement was gradually increased until subjects
were responding under a FR 20 schedule of reinforcement. The criterion for
discrimination was specified as at least 80% responding on the correct lever prior to
the delivery of the first reinforcer for nine out of 10 consecutive sessions.
Testing Procedures
Upon reaching criterion, differential outcome subjects completed a no-odor
cue test. Subjects who received milk after saline injections received a saline injection
and were tested without milk present in the chambers; subjects who received milk
after cocaine injections received a cocaine injection (lOmg/kg) and were tested
without milk present in the chambers. This was done to determine whether subjects
were discriminating between the presence and absence of drug or between olfactory
stimuli. Stimulus generalization to the training drug was tested using several doses of
cocaine (0.0, 1.25, 2.5, 5.0, 10.0 mg/kg). Following cocaine generalization tests,
stimulus generalization tests were administered using several different doses of
(±)-7-OH-DPAT (0.0, 0.01, 0.03, 0.1, 0.3 mg/kg SC), PD 128907 (0.0, 0.01, 0.03,
0.1, 0.3 mg/kg IP), and (+)-7-OH-DPAT (0.0, 0.01, 0.03, 0.1, 0.3 mg/kg IP). In
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addition, two doses of (+)-7-OH-DPAT (0.1, 0.3 mg/kg) and PD 128907 (0.1, 0.3
mg/kg) were administered SC. Test sessions were conducted in a similar manner to
training sessions with the exception that no reinforcers were delivered and subjects
were removed from the chambers upon completion of 20 consecutive responses on
either lever or when 20 min elapsed, whichever came first. Prior to each testing
session, subjects received a drug and a saline training condition, and were required to
maintain the 80% criterion under both training conditions before each test was
administered.
Data Analysis
Dose response data were presented as the percent of total responses made on
the drug-appropriate lever during test sessions. Response rate was presented as the
number of responses made (on either lever) per second during test sessions. In the
event that an animal did not complete at least 15 total responses during a test session,
the percentage of drug-lever responses for that test was not included in the statistical
analyses. The number of sessions required for each group to attain discrimination
criterion was analyzed using a two-sample t test; the data from the substitution tests
were analyzed using a two-factor (group x dose) analysis of variance. Because the
data from substitution tests were presented as the percentage of the total responses
made on the drug-appropriate lever, generalization was said to have occurred if
responding on the drug-appropriate lever was at least 80%. Drug-appropriate
responding between 20% and 80% was considered evidence for partial substitution.
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For drugs that produced stimulus generalization, the dose-response curves were also
analyzed using a nonlinear regression and ED50s and confidence intervals were
calculated. Statistical analyses were conducted using GraphPad Prism (GraphPad,
Inc., San Diego, CA) software.

RESULTS
All subjects met the discrimination criterion stated above. After meeting the
initial criterion for discrimination, five animals in the control group began to exhibit
poor stimulus control due to equipment failure. After the equipment problem was
fixed, these animals were required to meet the discrimination criterion (10
consecutive sessions above 80% correct lever prior to the first reinforcer) again
before they were administered test sessions. Therefore, the sessions to criterion for
these five animals were not included in the statistical analysis. Figure 1 illustrates the
mean sessions to criterion for each group. The differential outcomes group met the
discrimination criterion in significantly fewer sessions than the control group
(t=2.823, p< 0.05). The mean number of sessions to criterion for the differential
outcomes group (n= l0) was 47.50 (S.E.M.= ± 2.491, Range: 31-59); the mean
number of sessions to criterion for the control group (n=7) was 66.14 (S.E.M. = ±
7.130, Range: 37-95).
Subjects in the differential outcomes group also completed a no-odor-cue test
upon reaching criterion. Subjects who received milk as the reinforcer after cocaine
injections received a cocaine injection (10 mg/kg) and were tested without milk
present in the chambers; subjects who received milk as the reinforcer after saline
injections received a saline injection and were tested without milk present in the
chambers. This was done to determine whether subjects were discriminating between
13
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the presence and absence of a drug or between olfactory cues. When tested in the
absence of milk odor, 10 of the 12 subjects in the differential outcomes group made
greater than 90% of their responses on the condition-appropriate lever. As it
appeared that two subjects were discriminating between olfactory cues, their data
were not included in any statistical analyses.
Since the remaining 22 subjects, including the five control subjects mentioned
previously, were required to meet the discrimination criterion prior to test phases, all
data from these 22 subjects are included in the tests of generalization and subsequent
analyses. The cocaine dose response data are displayed in Figure 2. All subjects
exhibited dose-dependent increases in drug appropriate responding. Statistical
analysis revealed a significant main effect of dose on percent drug-appropriate
responding (F4,100=16.39, p<0.001). The EDso for the control group was 1.34 mg/kg
(95% Confidence Intervals: 0.36-4.93) and the ED 5o for the differential outcomes
group was 3.78 mg/kg (95% Confidence Intervals: 0.95-15.11). Although the EDso
for the control group was lower than the EDso for the differential outcomes group, a
two-factor (group x dose) ANOVA on the dose-response tests revealed no significant
difference between training groups.
The results of stimulus generalization tests with (±)-7-OH-DPAT (SC) are
displayed in Figure 3. (±)-7-OH-DPAT (SC) substituted for cocaine in a dose
dependent manner in both the control group (EDso= 0.02, 95% Confidence Interval:
0.01-0.09) and the differential outcomes group (ED 5o=0.04, 95% Confidence Interval:
0.01-0.20). Although this compound produced complete substitution for both groups
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at 0.1 and 0.3 mg/kg, it also dose-dependently reduced response rate. Fifteen of the
22 animals produced 9 or fewer responses when tested at 0.3 mg/kg. A two-factor
ANOVA showed a statistically significant reduction in response rate (F3 , 80=18.49,
p<0.001). Statistical analysis revealed no main effect of training group, indicating no
significant difference in generalization of (±)-7-OH-DPAT between the control group
and the differential outcomes group. Statistical analysis also showed a significant
main effect of dose (F3, ss=33.46, p< 0.001) on percent drug-appropriate responding.
Results of stimulus generalization tests with (+)-7-OH-DPAT (IP) are
illustrated in Figure 4. (+)-7-OH-DPAT (IP) also produced dose-dependent increases
in drug-appropriate responding, however, this compound produced only partial
substitution in either group at 0.3 mg/kg. A two-factor ANOVA showed a significant
main effect of dose on percent drug-appropriate responding (F4, 73=4.67, p<0.005).
IP administration of this compound also significantly reduced response rate (F4,
100

=1 l .84,

p<0.001) in a dose-dependent fashion. Higher doses were not examined

because 16 of the 22 animals produced 6 or fewer responses when tested at this dose.
Subjects were also tested with two doses of this compound (0.1, 0.3 mg/kg) following
SC injection (see Figure 5). At these doses, (+)-7-OH-DPAT (SC) produced
complete generalization in both the control group and the differential outcomes
group. However, statistical analysis of the data showed no significant difference in
generalization of (+)-7-OH-DPAT (IP and SC) between the control group and the
differential outcomes group.
Results of stimulus generalization tests with PD 128907 (IP) are illustrated in
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Figure 6. When administered IP, PD 128907 also produced only partial substitution
for cocaine in either group. As 10 of the 22 animals did not complete the FR
requirement when tested at 0.3 mg/kg, higher doses of this compound were not tested.
Animals in both groups exhibited complete generalization when PD 128907 (0.1, 0.3
mg/kg) was administered via SC injection (see Figure 7). This compound also
produced significant dose-dependent decreases in response rate, both IP (F4, 1oo=5.09,
p<0.005) and SC (Fi, 40=11.28, p<0.005). Again, a two-factor ANOVA showed no
significant difference in generalization of PD 128907 (IP and SC) between the control
group and the differential outcomes group. Statistical analysis revealed a significant
main effect of dose on percent drug-appropriate responding when administered both
IP (F4, 95 =14.44, p<0.001) and SC (F1, 34=10.76, p<0.005).

22

PD 128907 (IP)

z

"'

0 100
C.

�

a::
w
w.J
w
z
�

80
60

8

40

w
a::w

20

�

0

---CONTROL
-0-DIFF OUTCOMES

C.
0
0.0

0.01

0.03

0.1

0.3

DOSE (mg/kg)
2.0

C

z

... CONlROL

0
0

"'
"'w
"'z
0
"'w
w
a::
w

-0- DIFF

OUTCOMES

1.5

C.

1.0

C.

a::

0.5

0.0
0.0

0.01

0.03

0.10

0.3

DOSE (mg/kg)

Figure 6. Results of Stimulus Generalization Tests With PD 128907 (IP).

23
PD 128907 (SC)

ffi

100

z

(J)

� 80

(J)

�

a::
w 60
w

z
�

o

(.)

.. CONTROL

40

-(]- DIFF OUTCOMES

20
0-4---1-4'----------0.2
0.1
o.o
0.3
DOSE (mg/kg)

... CONTROL

� 1.00
0

-0- DIFF OUTCOME S

w
"' 0.75
a::
w
(.)

a.

ffi

0.50

z
0
a. 0.25
ti)

w
a::

ti)

0.00

0.0

0.1

0.2
DOSE (mg/kg)

0.3

Figure 7. Results of Stimulus Generalization Tests With PD 128907 (SC).

DISCUSSION
The initial objective of this study was to replicate the differential outcomes
effect on a saline-cocaine discrimination procedure in rats. The present study
successfully replicated the findings of a previous study (Morgan & Baker, 1997) in
which acquisition of a saline-cocaine discrimination was facilitated when differential
outcomes were applied during discrimination training. The findings of the present
study add more evidence to the hypothesis that differential outcomes can be used in
drug discrimination training to speed the acquisition of stimulus control. As seen by
the significant difference in sessions to criterion between the two training groups, the
present study lends more credibility to the idea that the use of differential outcomes
would enable investigators to reduce the time and effort necessary for such intensive
research. Previous findings (Morgan & Baker, 1997) revealed that the use of
differential outcomes during training did not significantly alter the cocaine dose
response curve. The results of the present study are consistent with this finding. The
study by Morgan & Baker (1997) found no significant differences in generalization to
other doses of the training drug, although there was some variability between the two
groups. Similarly, results of the present study did not reveal any significant
differences in the dose-response curves of the two groups, though it does appear that
there is some level of variability between the control group and the differential
outcomes group. Therefore, the present study offers more evidence that differential
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outcomes can be applied to cocaine-saline discrimination research to facilitate
acquisition of discrimination without significantly altering the cocaine dose-response
curve. Possibilities for future research may involve the application of differential
outcomes to other two-lever drug discriminations to investigate its potential to
facilitate the discrimination of other drugs, and even application to three-lever
discriminations. Although further research should be conducted to determine the
potential of the differential outcomes effect in facilitating the acquisition of all drug
discriminations, the results of the present study are promising.
Interestingly, stimulus generalization tests occurred more frequently for the
differential outcomes group than for the control group. It is possible that the
application of differential outcomes may have helped maintain stimulus control
between test sessions, allowing animals in the differential outcomes group to be
tested more frequently. Future research in this area should investigate differences in
terminal accuracy and differences in maintenance of stimulus control between
differential outcomes subjects and control subjects.
After completion of generalization testing, the differential outcomes group
was run an additional 10 sessions without the use of the differential outcomes. All
animals emitted 80% or greater responses on the condition-appropriate lever for at
least nine of the 10 sessions, suggesting that stimulus control was maintained by the
drug in the absence of olfactory cues.
The second objective of the present study was to examine whether the
differential outcomes conditions applied during training have an impact on the

26
generalization of the dopamine D3 receptor agonists (±) 7-OH-DPAT, (+) 7OHDPAT, and PD 128907 administered during substitution testing. Results of the
present study showed that there were no significant differences in generalization of
any of these compounds between the control group and differential outcomes group.
Results of generalization tests, with both the control and differential outcomes group,
in the present study are consistent with the results of investigations where differential
outcomes were not used. Results of the present study indicated that (±)-7-OH-DPAT
completely substituted for cocaine in animals trained on a cocaine-saline
discrimination. Acri et al. (1995) also found that (±)-7-OH-DPAT fully substituted
for cocaine in rats trained to discriminate cocaine from saline. Similarly, Lamas et al.
(1996) found that rhesus monkeys trained to discriminate cocaine from saline have
been shown to exhibit complete generalization to the selective D3 agonist (±)-7-OH
DPAT. Spealman (1996), however, found that 7-OH-DPAT only partially substituted
for cocaine in squirrel monkeys trained on a cocaine-saline discrimination. In the
investigations by Spealman, 7-OH-DPAT was administered intramuscularly (IM). In
the present study, this compound was administered IP. The differences in
generalization could be due the different routes of administration of 7-OH-DPAT or
due to the different species studied. In other assays, such as the self-administration
assay, 7-OH-DPAT has been found to substitute completely for cocaine in both rats
(Caine & Koob, 1997;) and rhesus monkeys (Nader & Mach, 1996).
Data from the present study also show that when administered IP, (+)-7-0H
DPAT only partially substituted for cocaine in rats trained on a cocaine-saline
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discrimination, regardless of training group. This finding is comparable to results of
other similar studies. However, when administered SC, 7-OH-DPAT completely
substituted for cocaine in both groups. This finding differs from that of other
investigations. For example, Baker et al. (1998) found that rats trained to
discriminate cocaine from saline exhibited only partial substitution to (+)-7-OHDPAT. This could be due to the fact that Baker et al. (1998) used a lower training
dose of cocaine (5.0 mg/kg), whereas a training dose of 10.0 mg/kg was used in the
present study.
When administered IP, PD 128907 also produced only partial substitution for
cocaine in both groups. This finding is consistent with other investigations.
Spealman (1996) also found that PD 128907 only partially substituted for cocaine in
squirrel monkeys trained on a cocaine-saline discrimination. However, when
administered SC, PD 128907 produced complete substitution for cocaine in both
training groups. This finding is consistent with other similar investigations. Acri et
al. (1995) also found that PD 128907 fully substituted for cocaine in rats trained to
discriminate cocaine from saline. Similarly, Lamas et al. (1996) found that rhesus
monkeys trained to discriminate cocaine from saline have been shown to exhibit
complete generalization to the selective D3 agonist PD 128907. In general, the
overall results of the (±)-7-OH-DPAT, (+)-7-OH-DPAT, and PD 128907 substitution
tests in the present study are consistent with the majority of the research on those
compounds. The most important finding, however, is that there were no significant
differences in the generalization of these test compounds between the two training
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groups.
In summary, the two primary objectives of the present study were to replicate
the differential outcomes effect on a cocaine-saline discrimination procedure in rats,
and to examine whether the differential outcomes applied during training have an
impact on the generalization of the selective dopamine-D3 receptor agonists (±)-7OH-DPAT, (+)-7-OH-DPAT, and PD 128907. The present study successfully
replicated the differential outcomes effect on a cocaine-saline discrimination in rats.
Additionally, the present study found no differences in the generalization of selective
DA D3 agonists to cocaine in between a group that learned the discrimination via
differential outcomes and a group that learned the discrimination without application
of differential outcomes. The present study adds to the evidence that the use of
differential outcomes in drug discrimination assays not only speeds discrimination
acquisition, but also do not significantly alter dose-response curves or generalization
to compounds with similar pharmacological mechanisms. Although more research is
needed, it can be suggested that differential outcomes can only benefit individuals
involved in drug discrimination research.

Appendix A
Protocol Clearance From the Institutional Animal
Care and Use Committee (IACUC)
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